APA (7th ed.) Citation

Thirumalaisamy, R., Vasuki, S., Sindhu, S. M., Mothilal, T. M., Srimathi, V., Poornima, B., . . . Hariharan, M. (2025). FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective. Molecular Biotechnology, 67(2), 469-483. https://doi.org/10.1007/s12033-024-01090-0

Chicago Style (17th ed.) Citation

Thirumalaisamy, R., S. Vasuki, S. M. Sindhu, T. M. Mothilal, V. Srimathi, B. Poornima, M. Bhuvaneswari, and Mohan Hariharan. "FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective." Molecular Biotechnology 67, no. 2 (2025): 469-483. https://doi.org/10.1007/s12033-024-01090-0.

MLA (9th ed.) Citation

Thirumalaisamy, R., et al. "FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective." Molecular Biotechnology, vol. 67, no. 2, 2025, pp. 469-483, https://doi.org/10.1007/s12033-024-01090-0.